Clinical Advisory Board

Our Clinical Advisory Board is composed of academic and industry leaders in the fields of neuroscience and depression. It was formed in early 2017 to guide the design and execution of the early clinical evaluation of NV-5138.

Maurizio Fava, MD

Dr. Fava is the executive vice chair of the Department of Psychiatry and executive director of the Clinical Trials Network and Institute at Massachusetts General Hospital (MGH), and an associate member of the Broad Institute’s Stanley Center for Psychiatric Research. He is also the director of the Depression Clinical and Research Program (DCRP) at MGH and the Slater Family Professor of Psychiatry at Harvard Medical School.

John H. Krystal, MD

Dr. Krystal is Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry and of Neuroscience, and Chair of the Department of Psychiatry. He is aso Chief of Psychiatry at the Yale-New Haven Hospital and Director of the NIAAA Center for the Translational Neuroscience of Alcoholism.

Steven Leventer, PhD

Dr. Leventer is an independent consultant with nearly 30 years of experience in drug development in neuropsychiatry. He was Vice President of Neuroscience at AstraZeneca and also served in senior roles at Quintiles and Wyeth.

Charles B. Nemeroff, MD, PhD

Dr. Nemeroff is acting Chair and Professor with the Department of Psychiatry and Director, Institute for Early Life Adversity Research at the Dell Medical School at the University of Texas at Austin. He is also a member of the Institute of Medicine of the National Academy of Sciences.

Gerard Sanacora, MD

Dr. Sanacora is Professor of Psychiatry at Yale University and Director of the Yale Depression Research Program. He is also Co-Director of the Yale New Haven Hospital Interventional Psychiatry Service and a member of the Yale Mood Disorders Research Program.

Steven D. Targum, MD

Dr. Targum is an independent consultant with over thirty years of clinical development experience across multiple new anti-depressant programs. He has been a Principal Investigator in over 200 company-sponsored clinical trials and has published over 150 scientific articles in the areas of psychopharmacology, psychobiology, and clinical trials methodology.

Madhukar Trivedi, MD

Dr. Trivedi is the Betty Jo Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care UT Southwestern Medical Center. He is also the Head, Center for Depression Research at the Peter O’Donnell Jr. Brain Institute.

Back to Top